PSA Levels refer to the measured concentration of Prostate-Specific Antigen (PSA) in the blood, a glycoprotein enzyme produced primarily by the cells of the prostate gland. While a rise in PSA levels can indicate prostate cancer, it is also elevated in non-malignant conditions like benign prostatic hyperplasia (BPH) and prostatitis. Monitoring these levels is a standard component of male urological and hormonal health surveillance. It is a critical, though non-specific, biomarker of prostate status.
Origin
PSA was first identified and isolated in the 1970s and subsequently adopted as a clinical biomarker for prostate health. The term ‘levels’ refers to the quantitative measurement used in clinical laboratory testing. Its utility as a screening tool has been the subject of extensive clinical discussion.
Mechanism
PSA functions as a serine protease, primarily responsible for liquefying the seminal fluid. Testosterone and its potent metabolite, dihydrotestosterone (DHT), regulate the production and secretion of PSA by the prostate epithelial cells. Therefore, fluctuations in androgen levels, as seen in male hormonal therapy, can directly influence the measured PSA concentration.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.